CN1309378C - 包含噻托铵盐的用于吸入的气雾制剂 - Google Patents

包含噻托铵盐的用于吸入的气雾制剂 Download PDF

Info

Publication number
CN1309378C
CN1309378C CNB038082330A CN03808233A CN1309378C CN 1309378 C CN1309378 C CN 1309378C CN B038082330 A CNB038082330 A CN B038082330A CN 03808233 A CN03808233 A CN 03808233A CN 1309378 C CN1309378 C CN 1309378C
Authority
CN
China
Prior art keywords
pharmaceutical preparation
tiotropium
formulation
milligrams
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
CNB038082330A
Other languages
English (en)
Chinese (zh)
Other versions
CN1646108A (zh
Inventor
卡林·德雷赫塞尔
巴巴拉·尼克劳斯-汉克
克里斯特尔·施梅尔泽
皮特拉·巴思
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Boehringer Ingelheim Pharma GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=28458728&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN1309378(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma GmbH and Co KG filed Critical Boehringer Ingelheim Pharma GmbH and Co KG
Publication of CN1646108A publication Critical patent/CN1646108A/zh
Application granted granted Critical
Publication of CN1309378C publication Critical patent/CN1309378C/zh
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/53861,4-Oxazines, e.g. morpholine spiro-condensed or forming part of bridged ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Nozzles (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CNB038082330A 2002-04-11 2003-04-02 包含噻托铵盐的用于吸入的气雾制剂 Ceased CN1309378C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10216036.8 2002-04-11
DE10216036A DE10216036A1 (de) 2002-04-11 2002-04-11 Aerosolformulierung für die Inhalation enthaltend ein Tiotropiumsalz

Publications (2)

Publication Number Publication Date
CN1646108A CN1646108A (zh) 2005-07-27
CN1309378C true CN1309378C (zh) 2007-04-11

Family

ID=28458728

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB038082330A Ceased CN1309378C (zh) 2002-04-11 2003-04-02 包含噻托铵盐的用于吸入的气雾制剂

Country Status (32)

Country Link
EP (2) EP1496876B1 (enExample)
JP (1) JP2005531528A (enExample)
KR (1) KR100997219B1 (enExample)
CN (1) CN1309378C (enExample)
AR (1) AR039286A1 (enExample)
AT (1) ATE389391T1 (enExample)
AU (1) AU2003222791B2 (enExample)
BR (1) BR0309080A (enExample)
CA (1) CA2473815C (enExample)
CO (1) CO5611150A2 (enExample)
CY (1) CY1108133T1 (enExample)
DE (2) DE10216036A1 (enExample)
DK (1) DK1496876T3 (enExample)
EA (1) EA007228B1 (enExample)
EC (1) ECSP045358A (enExample)
ES (1) ES2303897T3 (enExample)
HR (1) HRP20040932B1 (enExample)
ME (1) ME00359B (enExample)
MX (1) MXPA04009818A (enExample)
MY (1) MY137249A (enExample)
NO (1) NO334915B1 (enExample)
PE (1) PE20030970A1 (enExample)
PL (1) PL371204A1 (enExample)
PT (1) PT1496876E (enExample)
RS (1) RS50923B (enExample)
SA (1) SA03240192B1 (enExample)
SI (1) SI1496876T1 (enExample)
TW (1) TWI344851B (enExample)
UA (1) UA78994C2 (enExample)
UY (1) UY27754A1 (enExample)
WO (1) WO2003084519A2 (enExample)
ZA (1) ZA200405721B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1682541T3 (da) 2003-11-03 2010-06-28 Boehringer Ingelheim Int Fremgangsmåde til fremstilling af tiotropiumsalte
EP1915158A1 (en) * 2005-08-06 2008-04-30 Boehringer Ingelheim International GmbH Use of tiotropium salts in the treatment of severe persistant asthma
TWI389692B (zh) 2005-10-10 2013-03-21 Boehringer Ingelheim Int 用以吸入β-共效劑的氣溶膠調配物
EP1905440A1 (de) * 2006-09-06 2008-04-02 Boehringer Ingelheim Pharma GmbH & Co. KG Verwendung einer pharmazeutischen Zusammensetzung enthaltend ein Anticholinergikum zur Abtötung von Mikroorganismen und zur Behandlung von Atemwegsinfektionen
EP2044967A1 (de) * 2007-10-01 2009-04-08 Boehringer Ingelheim Pharma GmbH & Co. KG Zerstäuber
JP6335798B2 (ja) 2012-02-28 2018-05-30 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規噴射剤含有チオトロピウム製剤
RU2493827C1 (ru) * 2012-10-03 2013-09-27 Шолекс Девелопмент Гмбх Стабильный комбинированный раствор фенотерола гидробромида и ипратропия бромида
WO2015065223A1 (ru) * 2013-10-28 2015-05-07 Шолекс Девелопмент Гмбх Стабильный раствор фенотерола гидробромида
WO2015065219A1 (ru) * 2013-10-28 2015-05-07 Шолекс Девелопмент Гмбх Раствор ипратропия бромида
GB201507686D0 (en) * 2015-05-05 2015-06-17 Norton Healthcare Ltd A stable tiotropium nebuliser solution
US20180133151A1 (en) * 2016-11-16 2018-05-17 Glenmark Specialty S.A. Nebulized tiotropium
CN115209872B (zh) * 2020-03-19 2024-08-02 广州谷森制药有限公司 含有酒石酸左旋沙丁胺醇的可吸入制剂
CN114259481A (zh) * 2021-11-26 2022-04-01 南京华盖制药有限公司 一种奥达特罗复方吸入溶液

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1323186A (zh) * 1998-10-17 2001-11-21 贝林格尔英格海姆法玛公司 喷雾器用的二室管状容器

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3931041C2 (de) 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
SG45171A1 (en) 1990-03-21 1998-01-16 Boehringer Ingelheim Int Atomising devices and methods
IL107120A (en) 1992-09-29 1997-09-30 Boehringer Ingelheim Int Atomising nozzle and filter and spray generating device
DE19536903C2 (de) 1995-10-04 1998-09-10 Boehringer Ingelheim Int Vorrichtung zum Haltern eines fluidischen Bauteils
DE19536902A1 (de) 1995-10-04 1997-04-10 Boehringer Ingelheim Int Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
DE19545226C1 (de) 1995-12-05 1997-06-19 Boehringer Ingelheim Int Sperrspannwerk für einen federbetätigten Abtrieb
DE19653969A1 (de) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
DE19742439C1 (de) 1997-09-26 1998-10-22 Boehringer Ingelheim Int Mikrostrukturiertes Filter
HRP20030338B1 (en) * 2000-10-31 2011-09-30 Boehringer Ingelheim Pharma Gmbh & Co. Kg. Inhalative solution formulation containing a titropium salt

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1323186A (zh) * 1998-10-17 2001-11-21 贝林格尔英格海姆法玛公司 喷雾器用的二室管状容器

Also Published As

Publication number Publication date
CA2473815C (en) 2011-06-14
HK1078793A1 (en) 2006-03-24
MY137249A (en) 2009-01-30
ME00359B (me) 2011-10-10
AU2003222791A1 (en) 2003-10-20
CY1108133T1 (el) 2014-02-12
UA78994C2 (uk) 2007-05-10
MEP54308A (en) 2011-05-10
EA200401305A1 (ru) 2005-06-30
KR100997219B1 (ko) 2010-11-29
HRP20040932A2 (en) 2005-02-28
ES2303897T3 (es) 2008-09-01
WO2003084519A2 (de) 2003-10-16
ECSP045358A (es) 2004-11-26
AU2003222791B2 (en) 2008-09-25
PT1496876E (pt) 2008-04-15
AR039286A1 (es) 2005-02-16
ZA200405721B (en) 2006-05-31
HRP20040932B1 (hr) 2013-04-30
JP2005531528A (ja) 2005-10-20
UY27754A1 (es) 2003-11-28
EP1949892A1 (de) 2008-07-30
DE10216036A1 (de) 2003-10-23
RS87904A (sr) 2006-12-15
RS50923B (sr) 2010-08-31
CA2473815A1 (en) 2003-10-16
EA007228B1 (ru) 2006-08-25
WO2003084519A3 (de) 2003-12-24
MXPA04009818A (es) 2004-12-13
NO334915B1 (no) 2014-07-14
PL371204A1 (en) 2005-06-13
TW200401653A (en) 2004-02-01
SI1496876T1 (sl) 2008-08-31
DE50309414D1 (de) 2008-04-30
DK1496876T3 (da) 2008-06-02
KR20040097322A (ko) 2004-11-17
BR0309080A (pt) 2005-02-22
EP1496876B1 (de) 2008-03-19
CN1646108A (zh) 2005-07-27
NO20044001L (no) 2004-10-27
ATE389391T1 (de) 2008-04-15
PE20030970A1 (es) 2004-01-13
TWI344851B (en) 2011-07-11
EP1496876A2 (de) 2005-01-19
SA03240192B1 (ar) 2008-01-09
CO5611150A2 (es) 2006-02-28

Similar Documents

Publication Publication Date Title
US7579358B2 (en) Aerosol formulation for inhalation comprising an anticholinergic
US7611694B2 (en) Aerosol formulation for inhalation comprising an anticholinergic
US20040019073A1 (en) Aerosol formulation for inhalation containing a tiotropium salt
US20020111363A1 (en) Inhalable formulation of a solution containing a tiotropium salt
CA2495275C (en) Aerosol formulation for inhalation comprising an anticholinergic agent
CN1649588A (zh) 基于抗胆碱能药物及pde-iv抑制剂的新颖药物组合物
CN1309378C (zh) 包含噻托铵盐的用于吸入的气雾制剂
US20090075990A1 (en) Aerosol Formulation for Inhalation Containing an Anticholinergic Agent
US20060034775A1 (en) Aerosol formulation for inhalation containing an anticholinergic
US20090306065A1 (en) Aerosol formulation for inhalation containing an anticholinergic agent
US20090317337A1 (en) Aerosol formulation for inhalation containing an anticholinergic agent
US20090170839A1 (en) Aerosol formulation for inhalation containing an anticholinergic agent
US20090221626A1 (en) Aerosol formulation for inhalation containing an anticholinergic agent
CN1646126A (zh) 包含类固醇及新颖抗胆碱酯酶剂的药物
CN1473044A (zh) 含提欧川平盐的溶液的可吸入制剂
KR100853107B1 (ko) 티오트로피움 염을 함유하는 흡입액 제형
HK1078793B (en) Aerosol formulation for inhalation comprising a tiotropium salt
HK1081461A (en) Aerosol formulation for inhalation containing an anticholinergic agent
HK1060524B (en) Inhalative solution formulation containing a tiotropium salt
US20060153777A1 (en) Aerosol formulation for inhalation containing an anticholinergic
HK1123745A (en) Inhalation formulation of the solution comprising tiotropium salt
HK1085119A (en) Novel medicament compositions based on tiotropium salts and on salmeterol salts
NZ536282A (en) Aerosol formulation for inhalation comprising a tiotropium salt
HK1078794A (en) Medicaments containing steroids and a novel anticholinesterase drug

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1078793

Country of ref document: HK

C14 Grant of patent or utility model
GR01 Patent grant
CX01 Expiry of patent term

Granted publication date: 20070411

CX01 Expiry of patent term
IW01 Full invalidation of patent right

Decision date of declaring invalidation: 20220803

Decision number of declaring invalidation: 57504

Granted publication date: 20070411

IW01 Full invalidation of patent right